Expanding Dermatology Pipeline Will Unlock Future Treatment Horizons
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
22 Jul 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€13.30
15.8% undervalued intrinsic discount15 Aug
€11.20
1Y
26.6%7D
-1.1%